These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26799124)

  • 21. Generic initiation and antidepressant therapy adherence under Medicare Part D.
    Bao Y; Ryan AM; Shao H; Pincus HA; Donohue JM
    Am J Manag Care; 2013 Dec; 19(12):989-98. PubMed ID: 24512035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of medicare part D plan features on use of generic drugs.
    Tang Y; Gellad WF; Men A; Donohue JM
    Med Care; 2014 Jun; 52(6):541-8. PubMed ID: 24824538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings.
    Song H; Adamson A; Mostaghimi A
    JAMA Dermatol; 2017 Aug; 153(8):755-759. PubMed ID: 28453645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program.
    Socal MP; Bai G; Anderson GF
    JAMA Netw Open; 2021 Mar; 4(3):e210483. PubMed ID: 33651110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
    Jing Y; Johnston SS; Fowler R; Bates JA; Forbes RA; Hebden T
    J Med Econ; 2011; 14(6):777-86. PubMed ID: 21954966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications.
    Bennie M; Bishop I; Godman B; Barbui C; Raschi E; Campbell S; Miranda J; Gustafsson LL
    Int J Clin Pract; 2013 Feb; 67(2):170-80. PubMed ID: 23305478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Medicare Part D coverage gap on medication adherence.
    Zhang Y; Baik SH; Lave JR
    Am J Manag Care; 2013 Jun; 19(6):e214-24. PubMed ID: 23844750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to Antipsychotic Therapy: Association With Hospitalization and Medicare Spending Among Part D Enrollees With Schizophrenia.
    Roberto P; Brandt N; Onukwugha E; Perfetto E; Powers C; Stuart B
    Psychiatr Serv; 2017 Nov; 68(11):1185-1188. PubMed ID: 28760097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage.
    McWilliams JM; Zaslavsky AM; Huskamp HA
    JAMA; 2011 Jul; 306(4):402-9. PubMed ID: 21791689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.
    Desai RJ; Sarpatwari A; Dejene S; Khan NF; Lii J; Rogers JR; Dutcher SK; Raofi S; Bohn J; Connolly J; Fischer MA; Kesselheim AS; Gagne JJ
    BMJ; 2018 Apr; 361():k1180. PubMed ID: 29615391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do Restrictions on Antipsychotic Use Differ Between Medicare Part D Stand-Alone Versus Medicare Advantage Plans?
    Chou J; Brandt NJ; Loh FE; Stuart B
    Consult Pharm; 2017 Feb; 32(2):109-118. PubMed ID: 28569663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.
    Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP
    JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myopic and Forward Looking Behavior in Branded Oral Anti-Diabetic Medication Consumption: An Example from Medicare Part D.
    Sacks NC; Burgess JF; Cabral HJ; Pizer SD
    Health Econ; 2017 Jun; 26(6):753-764. PubMed ID: 27150938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Forecasting Medicaid Expenditures for Antipsychotic Medications.
    Slade EP; Simoni-Wastila L
    Psychiatr Serv; 2015 Jul; 66(7):713-8. PubMed ID: 25828875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generic escitalopram initiation and substitution among Medicare beneficiaries: A new user cohort study.
    Li C; Chen L; Huo N; Mishuk AU; Hansen RA; Harris I; Kiptanui Z; Wang Z; Qian J
    PLoS One; 2020; 15(4):e0232226. PubMed ID: 32353006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Pioneer Accountable Care Organizations vs traditional Medicare fee for service with spending, utilization, and patient experience.
    Nyweide DJ; Lee W; Cuerdon TT; Pham HH; Cox M; Rajkumar R; Conway PH
    JAMA; 2015 Jun; 313(21):2152-61. PubMed ID: 25938875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the introduction of generic latanoprost on glaucoma medication adherence.
    Stein JD; Shekhawat N; Talwar N; Balkrishnan R
    Ophthalmology; 2015 Apr; 122(4):738-47. PubMed ID: 25680226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
    Polinski JM; Mohr PE; Johnson L
    Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
    Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.